165 related articles for article (PubMed ID: 12482733)
1. Parathyroid hormone as a therapeutic agent.
Mitlak BH
Curr Opin Pharmacol; 2002 Dec; 2(6):694-9. PubMed ID: 12482733
[TBL] [Abstract][Full Text] [Related]
2. Safety of osteoanabolic therapy: a decade of experience.
Cipriani C; Irani D; Bilezikian JP
J Bone Miner Res; 2012 Dec; 27(12):2419-28. PubMed ID: 23165426
[No Abstract] [Full Text] [Related]
3. PTH analogues and osteoporotic fractures.
Verhaar HJ; Lems WF
Expert Opin Biol Ther; 2010 Sep; 10(9):1387-94. PubMed ID: 20629581
[TBL] [Abstract][Full Text] [Related]
4. Treatment of osteoporosis with parathyroid hormone and teriparatide.
Pleiner-Duxneuner J; Zwettler E; Paschalis E; Roschger P; Nell-Duxneuner V; Klaushofer K
Calcif Tissue Int; 2009 Mar; 84(3):159-70. PubMed ID: 19189037
[TBL] [Abstract][Full Text] [Related]
5. [Glucocorticoid and bone metabolism and disease].
Tanaka Y
Clin Calcium; 2013 Feb; 23(2):229-35. PubMed ID: 23354090
[TBL] [Abstract][Full Text] [Related]
6. The anabolic effects of parathyroid hormone.
Rubin MR; Cosman F; Lindsay R; Bilezikian JP
Osteoporos Int; 2002; 13(4):267-77. PubMed ID: 12030541
[No Abstract] [Full Text] [Related]
7. Parathyroid hormone added to established hormone therapy: effects on vertebral fracture and maintenance of bone mass after parathyroid hormone withdrawal.
Cosman F; Nieves J; Woelfert L; Formica C; Gordon S; Shen V; Lindsay R
J Bone Miner Res; 2001 May; 16(5):925-31. PubMed ID: 11341338
[TBL] [Abstract][Full Text] [Related]
8. Parathyroid hormone for the treatment of osteoporosis: a systematic review.
Cranney A; Papaioannou A; Zytaruk N; Hanley D; Adachi J; Goltzman D; Murray T; Hodsman A;
CMAJ; 2006 Jul; 175(1):52-9. PubMed ID: 16818910
[TBL] [Abstract][Full Text] [Related]
9. The potential of parathyroid hormone as a therapy for osteoporosis.
Rubin MR; Bilezikian JP
Int J Fertil Womens Med; 2002; 47(3):103-15. PubMed ID: 12081255
[TBL] [Abstract][Full Text] [Related]
10. Effects of parathyroid hormone alone or in combination with antiresorptive therapy on bone mineral density and fracture risk--a meta-analysis.
Vestergaard P; Jorgensen NR; Mosekilde L; Schwarz P
Osteoporos Int; 2007 Jan; 18(1):45-57. PubMed ID: 16951908
[TBL] [Abstract][Full Text] [Related]
11. Effects of parathyroid hormone on cancellous bone mass and structure in osteoporosis.
Miyakoshi N
Curr Pharm Des; 2004; 10(21):2615-27. PubMed ID: 15320749
[TBL] [Abstract][Full Text] [Related]
12. Treatment of osteoporosis with human parathyroid peptide and observations on effect of sodium fluoride.
Reeve J; Davies UM; Hesp R; McNally E; Katz D
BMJ; 1990 Aug; 301(6747):314-8. PubMed ID: 2393738
[TBL] [Abstract][Full Text] [Related]
13. Challenges in studying very rare cancer outcomes and infrequent exposures: example of teriparatide and osteosarcoma.
Andrews EB; Gilsenan A; Midkiff K; Harris D
Ann Epidemiol; 2016 Nov; 26(11):751-753. PubMed ID: 27645108
[No Abstract] [Full Text] [Related]
14. Therapy of male osteoporosis with parathyroid hormone.
Bilezikian JP; Kurland ES
Calcif Tissue Int; 2001 Oct; 69(4):248-51. PubMed ID: 11730261
[TBL] [Abstract][Full Text] [Related]
15. Clinical practice guidelines for the use of parathyroid hormone in the treatment of osteoporosis.
Hodsman A; ; Papaioannou A; ; Ann Cranney ;
CMAJ; 2006 Jul; 175(1):48. PubMed ID: 16818909
[No Abstract] [Full Text] [Related]
16. Effect of recombinant human parathyroid hormone (1-84) on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis: a randomized trial.
Greenspan SL; Bone HG; Ettinger MP; Hanley DA; Lindsay R; Zanchetta JR; Blosch CM; Mathisen AL; Morris SA; Marriott TB;
Ann Intern Med; 2007 Mar; 146(5):326-39. PubMed ID: 17339618
[TBL] [Abstract][Full Text] [Related]
17. Osteoporosis: trials and tribulations.
Seeman E
Am J Med; 1997 Aug; 103(2A):74S-87S; discussion 87S-89S. PubMed ID: 9302899
[TBL] [Abstract][Full Text] [Related]
18. Effects of calcitriol or calcium on bone mineral density, bone turnover, and fractures in men with primary osteoporosis: a two-year randomized, double blind, double placebo study.
Ebeling PR; Wark JD; Yeung S; Poon C; Salehi N; Nicholson GC; Kotowicz MA
J Clin Endocrinol Metab; 2001 Sep; 86(9):4098-103. PubMed ID: 11549632
[TBL] [Abstract][Full Text] [Related]
19. Anabolic skeletal therapy for osteoporosis.
Girotra M; Rubin MR; Bilezikian JP
Arq Bras Endocrinol Metabol; 2006 Aug; 50(4):745-54. PubMed ID: 17117299
[TBL] [Abstract][Full Text] [Related]
20. Reconstructing the skeleton with intermittent parathyroid hormone.
Seeman E; Delmas PD
Trends Endocrinol Metab; 2001 Sep; 12(7):281-3. PubMed ID: 11504661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
